Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,499 | 11 | 43.6% |
| Honoraria | $7,130 | 4 | 20.1% |
| Consulting Fee | $5,339 | 1 | 15.0% |
| Travel and Lodging | $4,045 | 16 | 11.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,070 | 1 | 5.8% |
| Food and Beverage | $1,456 | 23 | 4.1% |
| Education | $12.85 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Global Blood Therapeutics, Inc. | $19,181 | 23 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $16,057 | 25 | $0 (2021) |
| Novo Nordisk Inc | $125.00 | 1 | $0 (2024) |
| Alkermes, Inc. | $113.42 | 3 | $0 (2019) |
| Gilead Sciences, Inc. | $50.15 | 3 | $0 (2024) |
| Valeritas, Inc. | $18.65 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $175.15 | 4 | Novo Nordisk Inc ($125.00) |
| 2022 | $10,280 | 14 | Global Blood Therapeutics, Inc. ($10,280) |
| 2021 | $8,918 | 10 | Global Blood Therapeutics, Inc. ($8,900) |
| 2020 | $4,508 | 4 | Novartis Pharmaceuticals Corporation ($4,508) |
| 2019 | $11,545 | 21 | Novartis Pharmaceuticals Corporation ($11,532) |
| 2018 | $126.53 | 4 | Alkermes, Inc. ($100.57) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 08/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.98 | General |
| 06/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.49 | General |
| 05/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.68 | General |
| 11/03/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Honoraria | Cash or cash equivalent | $2,070.00 | General |
| Category: Sickle Cell Disease | ||||||
| 11/03/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $122.06 | General |
| Category: Sickle Cell Disease | ||||||
| 11/03/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $116.25 | General |
| Category: Sickle Cell Disease | ||||||
| 10/31/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Honoraria | Cash or cash equivalent | $230.00 | General |
| Category: Sickle Cell Disease | ||||||
| 10/27/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Honoraria | Cash or cash equivalent | $2,760.00 | General |
| Category: Sickle Cell Disease | ||||||
| 10/27/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $325.55 | General |
| Category: Sickle Cell Disease | ||||||
| 10/27/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $136.85 | General |
| Category: Sickle Cell Disease | ||||||
| 10/27/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Sickle Cell Disease | ||||||
| 10/27/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $60.00 | General |
| Category: Sickle Cell Disease | ||||||
| 09/07/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $64.52 | General |
| Category: Sickle Cell Disease | ||||||
| 06/24/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Honoraria | Cash or cash equivalent | $2,070.00 | General |
| Category: Sickle Cell Disease | ||||||
| 06/24/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $105.24 | General |
| Category: Sickle Cell Disease | ||||||
| 01/08/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,070.00 | General |
| Category: Sickle Cell Disease | ||||||
| 01/08/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Sickle Cell Disease | ||||||
| 08/05/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,610.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 08/05/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $122.03 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 08/05/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $38.08 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 07/27/2021 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: HEMATOLOGY | ||||||
| 06/24/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $920.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 03/19/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,265.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 02/24/2021 | Global Blood Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,035.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 298 | 299 | $5,922 | $5,447 |
| 2021 | 1 | 13 | 13 | $0.13 | $0.13 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 77 | 77 | $3,080 | $2,805 | 91.1% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 47 | 47 | $1,880 | $1,748 | 93.0% |
| 0051A | Adm sarscv2 30mcg trs-sucr 1 | Office | 2022 | 24 | 24 | $960.00 | $892.52 | 93.0% |
| 91313 | Coronavirus vaccine 14 | Office | 2022 | 77 | 77 | $0.77 | $0.77 | 100.0% |
| 91306 | Sarscov2 vac 50mcg/0.25ml im | Office | 2022 | 48 | 48 | $0.48 | $0.48 | 100.0% |
| 91305 | Sarscov2 vac 30 mcg trs-sucr | Office | 2022 | 25 | 26 | $0.26 | $0.26 | 100.0% |
| 91301 | Sarscov2 vac 100mcg/0.5ml im | Office | 2021 | 13 | 13 | $0.13 | $0.13 | 100.0% |
About Dr. Mamle Anim, MD
Dr. Mamle Anim, MD is a Internal Medicine healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790741536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mamle Anim, MD has received a total of $35,552 in payments from pharmaceutical and medical device companies, with $175.15 received in 2024. These payments were reported across 57 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,499).
As a Medicare-enrolled provider, Anim has provided services to 311 Medicare beneficiaries, totaling 312 services with total Medicare billing of $5,447. Data is available for 2 years (2021–2022), covering 7 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Dayton, OH
- Active Since 04/21/2006
- Last Updated 08/26/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1790741536
Products in Payments
- OXBRYTA (Drug) $14,236
- ADAKVEO (Biological) $12,022
- Vivitrol 380 mg (Drug) $100.57
- V-GO (Device) $18.65
- Vivitrol (Drug) $12.85
- Endari (Drug) $7.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dayton
Miguel Parilo, Md, MD
Internal Medicine — Payments: $165,368
Dr. Isaac Humphrey, M.d, M.D
Internal Medicine — Payments: $150,806
Kirshan Lal, Md, MD
Internal Medicine — Payments: $82,779
Dr. Daniel Pearson, M.d, M.D
Internal Medicine — Payments: $61,416
Dr. Mohamed Elmouelhi, Md, Phd, MD, PHD
Internal Medicine — Payments: $44,032
Dr. Glenda Lopez-Blaza, M.d, M.D
Internal Medicine — Payments: $33,145